Regencell Bioscience Holdings LTD Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Regencell (BVI) Limited and Yat-Gai Au have updated their beneficial ownership in Regencell Bioscience Holdings Ltd, reflecting an 86.2% and 88.6% stake respectively, following a 38-for-one forward stock split.
NASDAQ
SCHEDULE 13D/A: Regencell CEO's Entity Consolidates Control with $6.2 Million Share Purchase, Boosting Stake to 86.2%
Regencell (BVI) Limited, an entity controlled by Regencell Bioscience Holdings Limited's CEO Yat-Gai Au, has acquired an additional 652,982 ordinary shares for $6.2 million, significantly increasing its beneficial ownership to 86.2% of the company.